Pharmaceutical manufacturing is facing an escalating threat from cybersecurity attacks. With critical operations and infrastructure controlled by operational technology (OT) and industrial control systems (ICS), cyber attacks can lead to severe disruptions, compromised safety, and data loss. As pharmaceutical companies become prime targets for cyber criminals, understanding these threats is crucial for executives.
Key Points from the White Paper:
- The Dragos 2022 ICS/OT Cybersecurity Year in Review shows an alarming 87% increase in ransomware attacks against industrial organisations, including pharmaceutical manufacturers.
- Limited visibility into OT networks leaves organisations vulnerable. Improved visibility can be achieved through centralised network and device logs, asset inventories, and data flow inspections.
- Poor security perimeters, flat networks, and inadequate firewall rules expose critical assets to potential breaches.
- External connections can circumvent network security, and failure to control and monitor these connections is a concern.
- Shared IT and OT user accounts pose risks, and effective incident response in OT environments requires specialized planning.
- Tabletop exercises (TTXs) are a practical way to simulate attack scenarios and identify strengths and weaknesses in incident response capabilities.
Learn more about the cybersecurity challenges facing pharmaceutical manufacturing and how to protect your operations. Download our comprehensive white paper today.
